Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bott

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
American Journal of Hematology|August 6, 2019
Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolismWaldemar E Wysokinski, Damon E Houghton, Ana I Casanegra, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 6, 2021
Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk scoreJulia M Grottenthaler, Annette Konzelmann, Anette Stiegler, et al.
Mayo Clinic Proceedings|December 9, 2017
Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical LocationDawid T Janczak, Malgorzata K Mimier, Robert D McBane, et al.
Autonomic Neuroscience : Basic & Clinical|July 19, 2014
Decreased orthostatic adrenergic reactivity in non-dipping postural tachycardia syndromeJuan J Figueroa, Darlene M Bott-Kitslaar, Joaquin A Mercado, et al.
JAMA|September 23, 2016
Association Between Hospital Participation in a Medicare Bundled Payment Initiative and Payments and Quality Outcomes for Lower Extremity Joint Replacement EpisodesLaura A Dummit, Daver Kahvecioglu, Grecia Marrufo, et al.
European Journal of Haematology|June 20, 2020
Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweightWaldemar E Wysokinski, David A Froehling, Damon E Houghton, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 17, 2020
Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary EmbolismJulia C Cambron, Elias S Saba, Robert D McBane, et al.
Journal of Natural Products|August 9, 2016
Affinity Crystallography: A New Approach to Extracting High-Affinity Enzyme Inhibitors from Natural ExtractsAdeleke H Aguda, Vincent Lavallee, Ping Cheng, et al.
Mayo Clinic Proceedings|February 10, 2019
Apixaban and Rivaroxaban in Patients With Acute Venous ThromboembolismDalene M Bott-Kitslaar, Robert D McBane, Ana I Casanegra, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
American Journal of Hematology|August 6, 2019
Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer-associated venous thromboembolismWaldemar E Wysokinski, Damon E Houghton, Ana I Casanegra, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 6, 2021
Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk scoreJulia M Grottenthaler, Annette Konzelmann, Anette Stiegler, et al.
Mayo Clinic Proceedings|December 9, 2017
Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical LocationDawid T Janczak, Malgorzata K Mimier, Robert D McBane, et al.
Autonomic Neuroscience : Basic & Clinical|July 19, 2014
Decreased orthostatic adrenergic reactivity in non-dipping postural tachycardia syndromeJuan J Figueroa, Darlene M Bott-Kitslaar, Joaquin A Mercado, et al.
JAMA|September 23, 2016
Association Between Hospital Participation in a Medicare Bundled Payment Initiative and Payments and Quality Outcomes for Lower Extremity Joint Replacement EpisodesLaura A Dummit, Daver Kahvecioglu, Grecia Marrufo, et al.
European Journal of Haematology|June 20, 2020
Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweightWaldemar E Wysokinski, David A Froehling, Damon E Houghton, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 17, 2020
Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary EmbolismJulia C Cambron, Elias S Saba, Robert D McBane, et al.
Journal of Natural Products|August 9, 2016
Affinity Crystallography: A New Approach to Extracting High-Affinity Enzyme Inhibitors from Natural ExtractsAdeleke H Aguda, Vincent Lavallee, Ping Cheng, et al.
Mayo Clinic Proceedings|February 10, 2019
Apixaban and Rivaroxaban in Patients With Acute Venous ThromboembolismDalene M Bott-Kitslaar, Robert D McBane, Ana I Casanegra, et al.
Pageof 8